The Adverse Effects of High-dose Corticosteroids with Early and Late Severe Morbidity in the Treatment of Patients with Multiple Sclerosis: Long-term Observation Results
Journal Title: Turkish Journal of Neurology - Year 2019, Vol 25, Issue 2
Abstract
Objective: Intravenous methylprednisolone (IVMP) is the most commonly used emergency treatment for multiple sclerosis (MS) attacks and the risk of adverse effects is high due to frequent use. The aim of our study was to investigate the relationship between adverse effects that can lead to severe morbidity and possible pharmaceutic and/or physiologic causes. Materials and Methods: This study included patients with clinically definite MS who underwent IVMP treatment between 2010-2018. The corticosteroid treatment dose and duration, demographic characteristics, laboratory findings and adverse effect profiles of the patients were examined. Results: The medical records of 390 patients (F/M=294/96) with follow-up were evaluated retrospectively. Eleven (F/M=8/3) patients who developed severe complications after IVMP were detected. The drug infusion was ceased in two patients due to severe allergic reactions or tachyarrhythmia. One patient with severe tachycardia and two patients with corticosteroid-induced allergy received IVMP therapy along with alternative treatment and observation methods. In nine patients, avascular bone necrosis (AVN) developed after the treatment. AVN was multifocal in six patients and monofocal in three patients. The most frequently affected localization was the femoral head (six patients), followed by the tibia and talus. Only one patient had a high and repeated-dose (42 g total) drug use. Two patients received single-dose IVMP treatment. Conclusion: In our study, the treatment-related complications of patients diagnosed as having clinical definite MS and receiving IVMP were defined and it was thought that they might not be related to drug dose and duration.
Authors and Affiliations
Sami Ömerhoca, Sinem Yazıcı Akkaş, Zerrin Yıldırım Haşimoğlu, Sebatiye Erdoğan, Nilüfer Kale
Keywords
Related Articles
- EP ID EP48809
- DOI 10.4274/tnd.galenos.2019.75725
- Views 385
- Downloads 0
Palliative Care Requirement in Neurologic Diseases
Objective: It has been reported that the need for palliative care (PC) increases every day in chronic critical illnesses such as neurologic disorders. We investigated the demographics and comorbidities of neurological pa...
Cockayne Syndrome as a Rare Cause of Hemiplegia: Review of the Literature Accompanied by a Case Report
Cockayne syndrome is a rare genetic disease that presents with growth retardation, premature aging, retinal and generalized neurologic abnormalities. The presented case is a 29-year-old male patient, who was previously d...
Retrospective Evaluation of Carotid Artery Stenting Experience of Neurology Clinic of Selçuk University
Objective: Thirty percent of all acute ischemic strokes cause is the internal carotid artery stenosis or occlusion. The carotid artery stenting (CAS) was rarely performed in early time, was used more frequently with the...
Thrombolytic Therapy for Stroke in Turkey: Meta-analysis of Published Case Series
Objective: To evaluate the results of published case series originating from Turkey, which may be useful for system planning and institutional goal setting in the clinical practice of intravenous tissue plasminogen activ...
Anti-glutamic Acid Decarboxylase Antibody-associated Cerebellar Ataxia: A Case Report
Anti-glutamic acid decarboxylase antibodies (anti-GAD-ab) are associated with various neurologic conditions. High titers of anti-GAD-abs are observed in stiff person syndrome and subacute cerebellar degeneration. Type 1...